PEOPLE - Programme managers at new UK Centre for Evidence-based Purchasing
This article was originally published in Clinica
Executive Summary
Paul Garden, Martin Glasspool and Stephen Harbron are to manage the medical device evaluation programme of the UK's new Centre for Evidence-based Purchasing. From today, the CEP replaces the Device Evaluation Service, following its transfer from the Medicines and Healthcare products Regulatory Agency (MHRA) to the Purchasing and Supply Agency (PaSA). Sue Wilkin continues as head of the service.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.